Cleared Traditional

K973358 - MYOGLOBIN CONTROL SET

K973358 is an FDA 510(k) clearance for MYOGLOBIN CONTROL SET, manufactured by Boehringer Mannheim Corp.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 28-day FDA review.

K973358 · Boehringer Mannheim Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1997
Decision
28d
Days
Class 1
Risk

K973358 is an FDA 510(k) clearance for the MYOGLOBIN CONTROL SET. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Boehringer Mannheim Corp. (Pleasanton, US). The FDA issued a Cleared decision on October 6, 1997 after a review of 28 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boehringer Mannheim Corp. devices

FDA 510(k) Submission Details - K973358

510(k) Number K973358 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 08, 1997
Decision Date October 06, 1997
Days to Decision 28 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
60d faster than avg
Panel avg: 88d · This submission: 28d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 381
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K973358.
ELECSYS CALCHECK VITAMIN B12
K974383 · Boehringer Mannheim Corp. · Dec 1997
SERUM HCG CONTROL SET (NEGATIVE, LOW POSITIVE AND HIGH POSITIVE)
K974108 · Quidel Corp. · Nov 1997
OPUS HLH CONTROLS
K973832 · Behring Diagnostics, Inc. · Oct 1997
WAKO NEFA LINEARITY SET
K973072 · Wako Chemicals USA, Inc. · Sep 1997
ROCHE HEMOGLOBIN A1C CONTROL N AND CONTROL P
K972721 · Roche Diagnostic Systems, Inc. · Aug 1997
DADE TRU-LIQUID BILIRUBIN CONTROL
K972287 · Dade Intl., Inc. · Jul 1997